IL-21和Tfh细胞介导NSCLC免疫治疗的研究进展

非小细胞肺癌(non-small cell lung cancer,NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏制病情的进展,导致预后效果并不理想.尽管近年来免疫治疗药物的出现为NSCLC治疗带来了新希望,显示出一定的治疗效果,但当前的疗效仍显不足,无法满足所有患者的治疗需求.因此积极探索新的免疫治疗手段来进一步降低患者的死亡率,已成为NSCLC研究领域的重要方向.本文旨在通过梳理和分析国内外相关文献,系统综述白细胞介素21(interleukin-21,IL-21)和滤泡辅助性T细胞(follicular help...

Full description

Saved in:
Bibliographic Details
Published inZhongguo fei ai za zhi Vol. 27; no. 7; pp. 550 - 558
Main Authors 刘兴锴, 张一帆, 张鑫, 何功浩, 蔡文科
Format Journal Article
LanguageChinese
English
Published No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052 650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科 20.07.2024
650500 昆明,昆明医科大学%650032 昆明,中国人民解放军联勤保障部队第九二○医院呼吸与危重症医学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院临床药学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
Editorial board of Chinese Journal of Lung Cancer
Subjects
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/j.issn.1009-3419.2024.101.19

Cover

Abstract 非小细胞肺癌(non-small cell lung cancer,NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏制病情的进展,导致预后效果并不理想.尽管近年来免疫治疗药物的出现为NSCLC治疗带来了新希望,显示出一定的治疗效果,但当前的疗效仍显不足,无法满足所有患者的治疗需求.因此积极探索新的免疫治疗手段来进一步降低患者的死亡率,已成为NSCLC研究领域的重要方向.本文旨在通过梳理和分析国内外相关文献,系统综述白细胞介素21(interleukin-21,IL-21)和滤泡辅助性T细胞(follicular helper T cells,Tfh)在NSCLC免疫治疗中的抗肿瘤作用,并探讨通过免疫治疗手段调控免疫检查点,以改善NSCLC治疗前景的可能性.
AbstractList 非小细胞肺癌(non-small cell lung cancer,NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏制病情的进展,导致预后效果并不理想.尽管近年来免疫治疗药物的出现为NSCLC治疗带来了新希望,显示出一定的治疗效果,但当前的疗效仍显不足,无法满足所有患者的治疗需求.因此积极探索新的免疫治疗手段来进一步降低患者的死亡率,已成为NSCLC研究领域的重要方向.本文旨在通过梳理和分析国内外相关文献,系统综述白细胞介素21(interleukin-21,IL-21)和滤泡辅助性T细胞(follicular helper T cells,Tfh)在NSCLC免疫治疗中的抗肿瘤作用,并探讨通过免疫治疗手段调控免疫检查点,以改善NSCLC治疗前景的可能性.
非小细胞肺癌(non-small cell lung cancer, NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏制病情的进展,导致预后效果并不理想。尽管近年来免疫治疗药物的出现为NSCLC治疗带来了新希望,显示出一定的治疗效果,但当前的疗效仍显不足,无法满足所有患者的治疗需求。因此积极探索新的免疫治疗手段来进一步降低患者的死亡率,已成为NSCLC研究领域的重要方向。本文旨在通过梳理和分析国内外相关文献,系统综述白细胞介素21(interleukin-21, IL-21)和滤泡辅助性T细胞(follicular helper T cells, Tfh)在NSCLC免疫治疗中的抗肿瘤作用,并探讨通过免疫治疗手段调控免疫检查点,以改善NSCLC治疗前景的可能性。
Abstract_FL Non-small cell lung cancer(NSCLC)is a prevalent and aggressive global malignancy.Conventional sur-gical treatments,radiotherapy,chemotherapy,and targeted therapies often fall short in halting disease progression due to inher-ent limitations,resulting in suboptimal prognosis.Despite the advent of immunotherapy drugs offering new hope for NSCLC treatment,current efficacy remains insufficient to meet all patient needs.Therefore,actively exploring novel immunotherapeu-tic approaches to further reduce mortality rates in NSCLC patients has become a crucial focus of NSCLC research.This article aims to systematically review the anti-tumor effects ofinterleukin-21 and follicular helper T cells in NSCLC immunotherapy by summarizing and analyzing relevant literatures from both domestic and international sources,as well as exploring the potential for enhancing NSCLC treatment prospects through immune checkpoint regulation via immunotherapeutic means.
Author 张一帆
何功浩
蔡文科
刘兴锴
张鑫
AuthorAffiliation 650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科;650500 昆明,昆明医科大学%650032 昆明,中国人民解放军联勤保障部队第九二○医院呼吸与危重症医学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院临床药学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
AuthorAffiliation_xml – name: 650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科;650500 昆明,昆明医科大学%650032 昆明,中国人民解放军联勤保障部队第九二○医院呼吸与危重症医学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院临床药学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
Author_FL Yifan ZHANG
Xin ZHANG
Xingkai LIU
Wenke CAI
Gonghao HE
Author_FL_xml – sequence: 1
  fullname: Xingkai LIU
– sequence: 2
  fullname: Yifan ZHANG
– sequence: 3
  fullname: Xin ZHANG
– sequence: 4
  fullname: Gonghao HE
– sequence: 5
  fullname: Wenke CAI
Author_xml – sequence: 1
  fullname: 刘兴锴
– sequence: 2
  fullname: 张一帆
– sequence: 3
  fullname: 张鑫
– sequence: 4
  fullname: 何功浩
– sequence: 5
  fullname: 蔡文科
BookMark eNpVkM1Kw0AUhQepWFt9C8FV4tyZ6UxmJRL8KQRd2H2YpJk2pU1KYhW79WejbkQrKIhbcSG6cFPBlzGmj2GkunB1zuUcPi6ngkpRHAUILQE2qRBypWOGaRqZgLE0KANpEkxYcYIJcgbNg5TS4GCJUuH_OmVUSdMOxpxIyuZQmUpgQgCeR6LuGASyy_OGbufj08nR_ef4LHt-3961HTs7uchHT1-v43x0k98e5w9X-ePb5OMue7leQLNaddNg8VerqLGx3rC3DGdns26vOUbfsojBueIMWCA9i0hM_abHLAysxinT3JNKCEIEp8CF7zNGtJZaezVfCOHzpkV8WkWrU2x_4PWCph9Ee4nquv0k7Knk0I1V6P5PorDttuJ9F4BSIDVWEJanhAMVaRW13E48SKLiZXfY0mo4_FkPCwyEfgPT0nPU
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
版权所有 © 2024《中国肺癌杂志》编辑部 Copyright © 2024, Chinese Journal of Lung Cancer. 2024 Chinese Journal of Lung Cancer
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: 版权所有 © 2024《中国肺癌杂志》编辑部 Copyright © 2024, Chinese Journal of Lung Cancer. 2024 Chinese Journal of Lung Cancer
DBID 2B.
4A8
92I
93N
PSX
TCJ
5PM
DOI 10.3779/j.issn.1009-3419.2024.101.19
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Progress of IL-21 and Tfh Mediated Immunotherapy in Non-small Cell Lung Cancer
EISSN 1999-6187
EndPage 558
ExternalDocumentID PMC11331254
zgfazz202407012
GrantInformation_xml – fundername: 云南省中青年学术和技术带头人后备人才项目; Young and Middle-aged Academic and Technical Leaders Reserve Talent Project of Yunnan Province
  grantid: 202405AC350037
– fundername: 云南省中青年学术和技术带头人后备人才项目; Young and Middle-aged Academic and Technical Leaders Reserve Talent Project of Yunnan Province
  grantid: 2019HB045
GroupedDBID ---
-05
04C
29R
2B.
2WC
4A8
5GY
5VS
6PF
92F
92I
93N
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CCPQU
CIEJG
CW9
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PMFND
PQQKQ
PROAC
PSX
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
5PM
OVT
PUEGO
ID FETCH-LOGICAL-p882-66a6414e9b82903cdb480145634f6b9a7722763167cc442ff9ffb5c777c6d82c3
ISSN 1009-3419
IngestDate Tue Sep 30 17:08:07 EDT 2025
Thu May 29 03:56:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords 白细胞介素21
Interleukin-21
免疫检查点蛋白
Follicular helper T cells
滤泡辅助性T细胞
肺肿瘤
Immune checkpoint proteins
Lung neoplasms
Language Chinese
English
License This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p882-66a6414e9b82903cdb480145634f6b9a7722763167cc442ff9ffb5c777c6d82c3
OpenAccessLink http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.19
PMID 39147710
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11331254
wanfang_journals_zgfazz202407012
PublicationCentury 2000
PublicationDate 20240720
PublicationDateYYYYMMDD 2024-07-20
PublicationDate_xml – month: 7
  year: 2024
  text: 20240720
  day: 20
PublicationDecade 2020
PublicationPlace No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052
PublicationPlace_xml – name: No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052
PublicationTitle Zhongguo fei ai za zhi
PublicationTitle_FL Chinese Journal of Lung Cancer
PublicationYear 2024
Publisher 650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
650500 昆明,昆明医科大学%650032 昆明,中国人民解放军联勤保障部队第九二○医院呼吸与危重症医学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院临床药学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
Editorial board of Chinese Journal of Lung Cancer
Publisher_xml – name: 650500 昆明,昆明医科大学%650032 昆明,中国人民解放军联勤保障部队第九二○医院呼吸与危重症医学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院临床药学科%650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
– name: 650032 昆明,中国人民解放军联勤保障部队第九二○医院胸心外科
– name: Editorial board of Chinese Journal of Lung Cancer
SSID ssj0062934
ssib002262905
ssib044765436
ssib001103766
ssib038074678
ssib051369142
Score 2.4204454
Snippet 非小细胞肺癌(non-small cell lung cancer,NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏制病情...
非小细胞肺癌(non-small cell lung cancer, NSCLC)作为全球范围内频发且极具侵袭性的癌症之一,传统的手术治疗、放化疗及靶向治疗等方法往往由于其固有的局限性,难以遏...
SourceID pubmedcentral
wanfang
SourceType Open Access Repository
Aggregation Database
StartPage 550
SubjectTerms Review
Title IL-21和Tfh细胞介导NSCLC免疫治疗的研究进展
URI https://d.wanfangdata.com.cn/periodical/zgfazz202407012
https://pubmed.ncbi.nlm.nih.gov/PMC11331254
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib044765436
  issn: 1009-3419
  databaseCode: M~E
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: East & South Asia Database
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BVBZV
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastsouthasia
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BENPR
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQwMCqtqLggnqI8qh7wCWXZOI5jH-NsVgW1FYJF6m2VZJMul6WCVkh75XEBLgiKBBLiijggOHApEmf-g2X7GcxM0mxaKl5SNpo445nxjJ2xvfbYsi46sQuOOZZ25nnKFk7m2ho8ia16GccA5kncww3Oyyty8aa4uuqtTh36Vlu1tLmRNNLhgftK_seqkAZ2xV2y_2DZiigkAAz2hTtYGO5_ZeMrSzZ3WOQxzZkKO3mfRT4zhinJIsWUy3TEIkEpBtGCNjPhyo1wKcQnBVcLc2jJAngvmeGIW6Ron4CAKYFA0GS6ADQzRN60mSaqxmHFCZa7nVziqVjQItEMMy0SB4gHRFODsMhOtzARKQCpyh-SaIppVcpogK1G5kbUUUyIMhWcVJNSAJAHoEBmBwo4eSNQIu0R_YDpNhUdtKPrUyBc4Nwqb1aVFjqZTZdfIsEVqbgAcDnpQSUWWFwsMRBvogiggwD051JGeBuRAJK0CHQcUrCHpgoEZW-jhlB8EDJEACwaKEpRJDZQC_FCZE3IxBS1y9GAhdXhEa2qUfEBL2uGUaXiAcaaIdDmSBDs49Q8Ff6rhcH46q6sCLNQNlm_5pe8Irpv2cXximj5-70nxp4k74kMGhWDBqocZ3kaJbO98cmHa3k8HCIOeA8873uGg4NtTlszJlq5dn3SN8cdqfW5Ai65njgbPPgAnHblDITwcdtzhe85rtSOqGLDQeZiyciumLPw4SnKcPl3Jfh18fPhe_EgjwdrtX5l55h1tBwQLgRF6z5uTQ37J6zZ5XLJy0nLp0Y-evYEmvd4-9HO_Tfftx-PPnyhZjx6-HS89f7Hp-3x1svxqwfjt8_H7z7vfH09-vjilNVpR51w0S5PO7HXcZQrZSyFIzKd4NIGN-0lFNjJk67IZaJjGAWDXjFuRZoKwfNc53nipb7vp7KneOqetqYHtwfZGWsh50nq9rTCn1BOqnqxn3qZk7tJL_FkNmepPSrorheBbboYan7vm8GtPoWcdxzXhaGQmLMWSm11y-_g3e6-CnD2zyjnrCOTZnzemt64s5ldgL79RjJf1pp5mhv7Ccjsuag
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-21%E5%92%8CTfh%E7%BB%86%E8%83%9E%E4%BB%8B%E5%AF%BCNSCLC%E5%85%8D%E7%96%AB%E6%B2%BB%E7%96%97%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E5%88%98%E5%85%B4%E9%94%B4&rft.au=%E5%BC%A0%E4%B8%80%E5%B8%86&rft.au=%E5%BC%A0%E9%91%AB&rft.au=%E4%BD%95%E5%8A%9F%E6%B5%A9&rft.date=2024-07-20&rft.pub=650032+%E6%98%86%E6%98%8E%2C%E4%B8%AD%E5%9B%BD%E4%BA%BA%E6%B0%91%E8%A7%A3%E6%94%BE%E5%86%9B%E8%81%94%E5%8B%A4%E4%BF%9D%E9%9A%9C%E9%83%A8%E9%98%9F%E7%AC%AC%E4%B9%9D%E4%BA%8C%E2%97%8B%E5%8C%BB%E9%99%A2%E8%83%B8%E5%BF%83%E5%A4%96%E7%A7%91&rft.issn=1009-3419&rft.volume=27&rft.issue=7&rft.spage=550&rft.epage=558&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2024.101.19&rft.externalDocID=zgfazz202407012
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg